Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1188/week)
    • Manufacturing(599/week)
    • Technology(1138/week)
    • Energy(398/week)
    • aviation(137/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Merck & Co. Inc.

Jun 09, 2020
OncoSec Expands KEYNOTE-890 Trial into First-Line Metastatic Triple Negative Breast Cancer (mTNBC) with TAVO(TM) and KEYTRUDA® Plus Chemotherapy
Jan 22, 2020
Theramex Acquires Commercial Rights for Oral Contraceptive Zoely
Dec 02, 2019
Seattle Genetics and Astellas Announce Clinical Trial Collaboration with Merck to Evaluate Enfortumab Vedotin in Combination with KEYTRUDA® (pembrolizumab) in Patients with Metastatic Urothelial Cancer
Nov 08, 2019
BerGenBio Presents Updated Phase 2 NSCLC Clinical and Translational Data for Bemcentinib in Combination With KEYTRUDA®
Nov 06, 2019
4D pharma plc: Preliminary Safety and Clinical Observations From Its Phase I/II Study of MRx0518 in Combination With KEYTRUDA®
Nov 06, 2019
BerGenbio's Bemcentinib Meets Primary Endpoint in First Cohort of Phase 2 NSCLC Study in Combination With Keytruda®
Aug 12, 2019
Oncologie, Inc. Announces Clinical Trial Collaboration With Merck to Evaluate Bavituximab in Combination With KEYTRUDA® (Pembrolizumab) in Advanced Gastric or Gastroesophageal Cancer
Aug 06, 2019
Leap Presents Positive Clinical Results for the Combination of DKN-01 plus Keytruda® and Provides DKN-01 Program Update
Jun 05, 2019
Global Immunotherapy Drugs Market to 2025: Market will Grow at a CAGR of 12.5% - Key Vendors are AbbVie, Amgen, F. Hoffmann-La Roche, Bristol-Myers Squibb, Johnson & Johnson, & Merck & Co
May 21, 2019
Merck Animal Health Introduces BRAVECTO® Cares to Show Support for the Health of Service Dogs
Apr 30, 2019
The World Market for Esophageal Cancer - Forecast to 2023 with Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche, Merck & Co, and Sanofi Dominating
Apr 26, 2019
Global HDAC (histone deacetylase) Inhibitors Market to 2023 Featuring Celgene, Merck & Co, Novartis, Shenzhen Chipscreen Biosciences, & Spectrum Pharmaceuticals
Apr 15, 2019
Tessa Therapeutics Announces Collaboration with Merck Investigating the Combination of KEYTRUDA® (pembrolizumab) and Virus-Specific T Cell Therapy Targeting Human Papillomavirus in Cervical Cancer
Apr 02, 2019
BerGenBio Extends Phase II Trial With Bemcentinib and KEYTRUDA® in NSCLC to Include Patients With Disease Progression on Immune Checkpoint Inhibitor Therapy
Jan 03, 2019
Adlai Nortye Announces Clinical Collaboration with Merck to Evaluate Adlai Nortye's AN0025 (EP4 Antagonist) in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors
Dec 11, 2018
Roche to develop companion diagnostic test to help identify patients eligible for anti-PD-1 therapy based on biomarker expression, not location, of solid tumors
Dec 11, 2018
BioLineRx Announces Initiation of Triple Combination Arm of Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer Under Immuno-Oncology Collaboration
Nov 07, 2018
OncoSec Doses First Patient in KEYNOTE-890 Phase 2 Clinical Trial
Jul 30, 2018
BioLineRx Announces Expansion of Immuno-Oncology Collaboration in Pancreatic Cancer
Jun 26, 2018
Selective AXL Inhibitor Bemcentinib Meets Pre-specified Efficacy Endpoint in Stage 1 of NSCLC Phase II Combination Trial With KEYTRUDA®
  •  
  • Page 1
  • ››

Latest News

Jun 14, 2025

Gold Road Inc. Acquires Arizona Gold Mine, Upsizes Financing to C$3M, Welcomes Former Central Bank Governor...

Jun 14, 2025

President Trump Approves Historic Partnership between U. S. Steel and Nippon Steel

Jun 14, 2025

Federal Court in Delaware Dismisses Antitrust Challenge to Wabtec-GE Transportation Merger

Jun 14, 2025

EY US announces Gabriel Rio of Milestone Environmental Services as an Entrepreneur Of The Year® 2025 Gulf...

Jun 14, 2025

India plane crash orphans sisters after father's trip to scatter wife's ashes

Jun 14, 2025

Ram Brand Launches 'Never Stop Being American' Marketing Campaign, New Brand Ethos 'Nothing...

Jun 14, 2025

Klein Funding and Bybit Partner to Launch a New Era of Crypto Prop Trading

Jun 14, 2025

Xinhua Silk Road: 3rd Tianjin International Shipping Industry Expo kicks off to boost win-win cooperation

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia